Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1559-1182

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation ; day:15 ; month:6 ; year:2022 ; pages:1-18
Molecular neurobiology ; (15.6.2022), 1-18

Creator: Zhou, Chunyu
Jung, Cha-Gyun
Kim, Mi-Jeong
Watanabe, Atsushi
Abdelhamid, Mona
Taslima, Ferdous
Michikawa, Makoto

Contributor: SpringerLink (Online service)

DOI: 10.1007/s12035-022-02918-z

URN: urn:nbn:de:101:1-2022080918571931936485

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhou, Chunyu
Jung, Cha-Gyun
Kim, Mi-Jeong
Watanabe, Atsushi
Abdelhamid, Mona
Taslima, Ferdous
Michikawa, Makoto
SpringerLink (Online service)

Other Objects (12)

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Insulin Deficiency Increases Sirt2 Level in Streptozotocin-Treated Alzheimer’s Disease-Like Mouse Model: Increased Sirt2 Induces Tau Phosphorylation Through ERK Activation

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Comprehensive characterization of CK1δ-mediated tau phosphorylation in Alzheimer’s disease

Phosphorylation of different tau sites during progression of Alzheimer’s disease

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation

Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Related objects

Reset password